| Symbol | DXR |
|---|---|
| Name | DAXOR CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 107 MECO LANE, OAK RIDGE, TN 37830 |
| Telephone | 865-425-0555 |
| Fax | — |
| — | |
| Website | https://www.daxor.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000027367 |
| Description | Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Additional info from NASDAQ: |
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
Read moreDaxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
Read moreDaxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
Read moreDaxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
Read moreMichel Robert J 🟢 acquired 12.0K shares of DAXOR CORP (DXR) Transaction Date: Jun 23, 2026 | Filing ID: 030197
Read moreDirector Feldschuh Michael Richard 🟢 acquired 30.0K shares of DAXOR CORP (DXR) Transaction Date: Jun 23, 2026 | Filing ID: 030192
Read moreDirector Feldschuh Jonathan Adam 🟢 acquired 25.0K shares of DAXOR CORP (DXR) Transaction Date: Jun 23, 2026 | Filing ID: 030187
Read moreDirector Goudie Joy S. 🟢 acquired 2.5K shares (1 derivative) of DAXOR CORP (DXR) at $10.14 Transaction Date: Jun 23, 2026 | Filing ID: 030180
Read moreDirector Cremisi Henry D. 🟢 acquired 2.5K shares (1 derivative) of DAXOR CORP (DXR) at $10.14 Transaction Date: Jun 23, 2026 | Filing ID: 030175
Read moreDirector Feuer Edward 🟢 acquired 2.5K shares (1 derivative) of DAXOR CORP (DXR) at $10.14 Transaction Date: Jun 23, 2026 | Filing ID: 030171
Read more